Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30176% above fair value
$40.02−1.65 (-3.96%)
Close on Nov 17, 2026Market cap $1.87BP/E –Yield –
Septerna total assets
Total assets on the balance sheet at the end of each period.
Septerna's total assets was $619.40M at Sep 30, 2026. For fiscal 2025 it was $596.19M, up 30.6% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $596.19M | +30.6% |
| FY2024 | Dec 31, 2024 | $456.55M | +248.9% |
| FY2023 | Dec 31, 2023 | $130.87M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $619.40M | +2.1% |
| Q2 FY2026 | Jun 30, 2026 | $566.74M | +36.5% |
| Q1 FY2026 | Mar 31, 2026 | $569.69M | +31.3% |
| Q4 FY2025 | Dec 31, 2025 | $596.19M | +30.6% |
| Q3 FY2025 | Sep 30, 2025 | $606.65M | +248.1% |
| Q2 FY2025 | Jun 30, 2025 | $415.23M | +217.3% |
| Q1 FY2025 | Mar 31, 2025 | $434.02M | – |
| Q4 FY2024 | Dec 31, 2024 | $456.55M | – |
| Q3 FY2024 | Sep 30, 2024 | $174.28M | – |
| Q4 FY2023 | Dec 31, 2023 | $130.87M | – |
See a number that looks wrong?